Ulinastatin inhibits high glucose-induced cardiomyocyte apoptosis through activating Akt signaling

European Review for Medical and Pharmacological Sciences

Volumn 22, Issue 14, 2018, Pages 4691-4697

  Long, Y ^a   Zhang, Y ^a   Cai, S S ^a   Sun, D M ^a   Li, Y H ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Akt; Apoptosis; Cardiomyocyte; High glucose; Ulinastatin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; GLUCOSE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; ULINASTATIN; CASP3 PROTEIN, HUMAN; GLYCOPROTEIN;

AKT SIGNALING; ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NEWBORN; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STAINING; WESTERN BLOTTING; ANTIAPOPTOTIC ACTIVITY; ENZYME PHOSPHORYLATION; HEART CELL CULTURE; HEART PROTECTION; ANIMAL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CASPASE 3; GLUCOSE; GLYCOPROTEINS; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 85051205267     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 2013; 18: 149-166.
2. Trachanas K, Sideris S, Aggeli C, Poulidakis E, Gatzoulis K, Tousoulis D, Kallikazaros I. Diabetic cardiomyopathy: from pathophysiology to treatment. Hellenic J Cardiol 2014; 55: 411-421.
3. Bugger H, Abel ED . Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 2014; 57: 660-671.
4. Galloway CA, Yoon Y. Mitochondrial dynamics in diabetic cardiomyopathy. Antioxid Redox Signal 2015; 22: 1545-1562.
5. Lin N, Li XY, Zhang HM, Yang Z, Su Q. MicroRNA- 199a-5p mediates high glucose-induced reactive oxygen species production and apoptosis in INS-1 pancreatic beta-cells by targeting SIRT1. Eur Rev Med Pharmacol Sci 2017; 21: 1091-1098.
6. Wang ZM, Zhong CY, Zhao GJ. Polyphenol epigallocatechin- 3-gallate alleviates high glucose-induced H9C2 cell damage through PI3K/Akt pathway. Eur Rev Med Pharmacol Sci 2017; 21: 4236-4242.
7. Yamaguchi H, Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001; 20: 7779-7786.
8. Inoue K, Takano H, Shimada A, Yanagisawa R, Sakurai M, Yoshino S, Sato H, Yoshikawa T. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2005; 67: 673-680.
9. Xu CE, Zhang MY, Zou CW, Guo L. Evaluation of the pharmacological function of ulinastatin in experimental animals. Molecules 2012; 17: 9070-9080.
10. Cao YZ, Tu YY, Chen X, Wang BL, Zhong YX, Liu MH. Protective effect of Ulinastatin against murine models of sepsis: inhibition of TNF-alpha and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol 2012; 64: 543-547.
11. Si L, Xu J, Yi C, Xu X, Wang F, Gu W, Zhang Y, Wang X. Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-beta1-mediated hypertrophic signaling in vitro and in vivo. Int J Mol Med 2014; 34: 499-506.
12. Salier JP, Diarra-Mehrpour M, Sesboue R, Bourguignon J, Benarous R, Ohkubo I, Kurachi S, Kurachi K, Martin JP. Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha- trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI. Proc Natl Acad Sci U S A 1987; 84: 8272-8276.
13. Lepedda AJ, Nieddu G, Rocchiccioli S, Fresu P, De Muro P, Formato M. Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes. Electrophoresis 2013; 34: 3227-3233.
14. Hu CL, Li H, Xia JM, Li X, Zeng X, Liao XX, Zhan H, Jing XL, Dai G. Ulinastatin improved cardiac dysfunction after cardiac arrest in New Zealand rabbits. Am J Emerg Med 2013; 31: 768-774.
15. Masuda T, Sato K, Noda C, Ikeda KM, Mats unaga A, Ogura MN, Shimizu K, Nagasawa H, Matsuyama N, Izumi T. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 2003; 31: 1987-1992.
16. Xiao J, Zhu X, Ji G, Yang Q, Kang B, Zhao J, Yao F, Wu L, Ni X, Wang Z. Ulinastatin protects cardiomyocytes against ischemia reperfusion injury by regulating autophagy through mTOR activation. Mol Med Rep 2014; 10: 1949-1953.
17. Wang WK, Lu QH, Wang X, Wang B, Wang J, Gong HP, Wang L, Li H, Du YM. Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis. Exp Ther Med 2017; 14: 2497-2504.
18. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 2000; 101: 2618-2624.
19. Engel D, Peshock R, Armstong RC, Sivasubramanian N, Mann DL . Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 2004; 287: H1303-H1311.
20. Antonss on B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000; 256: 50-57.
21. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
22. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005; 38: 63-71.
23. Hong HJ, Liu JC, Chen PY, Chen JJ, Chan P, Cheng TH. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway. Int J Cardiol 2012; 157: 174-179.
24. Su D, Zhou Y, Hu S, Guan L, Shi C, Wang Q, Chen Y, Lu C, Li Q, Ma X. Role of GAB1/PI3K/AKT signaling high glucose-induced cardiomyocyte apoptosis. Biomed Pharmacother 2017; 93: 1197-1204.
25. Zhang B, Chen Y, Shen Q, Liu G, Ye J, Sun G, Sun X. Myricitrin attenuates high glucose-induced apoptosis through activating Akt-Nrf2 signaling in h9c2 cardiomyocytes. Molecules 2016; 21(7). pii: E880. doi:10.3390/molecules21070880.